Search - tctmd.com

Displaying 61 - 80 of 132

Sort: Relevancy | Date

Cardiac Intervention and Surgery RCTs Room for Improvement

News Daily News

Cardiac Intervention and Surgery RCTs: Room for Improvement?

June 03, 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

April 02, 2020

PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery

News Conference News ACC 2020

PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery

Yael L. Maxwell

March 31, 2020

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

News Conference News ACC 2020

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

March 28, 2020

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

March 16, 2020

EVAR—but Not Surgical AAA Repair—is Riskier Long-term for Women

News Daily News

EVAR—but Not Surgical AAA Repair—Is Riskier Long-term for Women

February 18, 2020

Combo of Proximal Protection, Double-Layer Stent May Enhance Carotid Stenting

News Daily News

Combo of Proximal Protection, Double-Layer Stent May Enhance Carotid Stenting

February 03, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2020

January 31, 2020

Top Stories in Cardiology: January 2019

Podcast Heart Sounds

Top Stories in Cardiology: January 2020

January 29, 2020

‘Sweet Spot’ Identified for BP During Stroke Thrombectomy

News Daily News

‘Sweet Spot’ Identified for BP During Stroke Thrombectomy

January 29, 2020

Overuse of CT Scans for Suspected Pulmonary Embolism Persists

News Daily News

Overuse of CT Scans for Suspected Pulmonary Embolism Persists

January 23, 2020

News Daily News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Michael O'Riordan

January 22, 2020

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

News Features

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

December 12, 2019

FDA Gives Rivaroxaban Another VTE-Related Indication

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

October 14, 2019

TCT 117: Novel optical coherence tomography classification of intravascular lesions in patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty.

Presentation TCT 2019

TCT 117: Novel optical coherence tomography classification of intravascular lesions in patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty.

Presenter: Stanislaw Jankiewicz

September 25, 2019

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

News Daily News

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

September 20, 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

August 22, 2019

FDA Gives Eagerly Awaited Update on Mortality With Paclitaxel-Coated Devices in PAD

News Daily News

FDA Gives Eagerly Awaited Update on Mortality With Paclitaxel-Coated Devices in PAD

August 07, 2019

Multiple Passes During Stroke Thrombectomy Ups Risk of Blood-Brain Barrier Disruption

News Daily News

Multiple Passes During Stroke Thrombectomy Ups Risk of Blood-Brain Barrier Disruption

Alison Palkhivala

July 05, 2019

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

News Daily News

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

June 10, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.